Camilla Karlsson1, Faazal Rehman2, Ruslan Damadzic2, Alison L Atkins1, Jesse R Schank3, Donald R Gehlert4, Pia Steensland5, Annika Thorsell1, Markus Heilig6. 1. Department of Clinical and Experimental Medicine, Linkopings University, Linkoping, Sweden. 2. Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), Bethesda, MD, USA. 3. Department of Physiology and Pharmacology, University of Georgia, Athens, GA, USA. 4. Neuroscience and Endocrine Discovery Research, Lilly Research Laboratories, a Division of Eli Lilly and Company, Indianapolis, IN, USA. 5. Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. 6. Department of Clinical and Experimental Medicine, Linkopings University, Linkoping, Sweden. markus.heilig@liu.se.
Abstract
RATIONALE: Melanin-concentrating hormone (MCH) is involved in the regulation of food intake and has recently been associated with alcohol-related behaviors. Blockade of MCH-1 receptors (MCH1-Rs) attenuates operant alcohol self-administration and decreases cue-induced reinstatement, but the mechanism through which the MCH1-R influences these behaviors remains unknown. MCH1-Rs are highly expressed in the nucleus accumbens shell (NAcSh) where they are co-expressed with dopamine (DA) receptors. MCH has been shown to potentiate responses to dopamine and to increase phosphorylation of DARPP-32, an intracellular marker of DA receptor activation, in the NAcSh. METHODS: In the present study, we investigated the role of the MCH1-R in alcohol reward using the conditioned place preference (CPP) paradigm. We then used immunohistochemistry (IHC) to assess activation of downstream signaling after administration of a rewarding dose of alcohol. RESULTS: We found that alcohol-induced CPP was markedly decreased in mice with a genetic deletion of the MCH1-R as well as after pharmacological treatment with an MCH1-R antagonist, GW803430. In contrast, an isocaloric dose of dextrose did not produce CPP. The increase in DARPP-32 phosphorylation seen in wildtype (WT) mice after acute alcohol administration in the NAcSh was markedly reduced in MCH1-R knock-out (KO) mice. CONCLUSION: Our results suggest that MCH1-Rs regulate the rewarding properties of alcohol through interactions with signaling cascades downstream of DA receptors in the NAcSh.
RATIONALE: Melanin-concentrating hormone (MCH) is involved in the regulation of food intake and has recently been associated with alcohol-related behaviors. Blockade of MCH-1 receptors (MCH1-Rs) attenuates operant alcohol self-administration and decreases cue-induced reinstatement, but the mechanism through which the MCH1-R influences these behaviors remains unknown. MCH1-Rs are highly expressed in the nucleus accumbens shell (NAcSh) where they are co-expressed with dopamine (DA) receptors. MCH has been shown to potentiate responses to dopamine and to increase phosphorylation of DARPP-32, an intracellular marker of DA receptor activation, in the NAcSh. METHODS: In the present study, we investigated the role of the MCH1-R in alcohol reward using the conditioned place preference (CPP) paradigm. We then used immunohistochemistry (IHC) to assess activation of downstream signaling after administration of a rewarding dose of alcohol. RESULTS: We found that alcohol-induced CPP was markedly decreased in mice with a genetic deletion of the MCH1-R as well as after pharmacological treatment with an MCH1-R antagonist, GW803430. In contrast, an isocaloric dose of dextrose did not produce CPP. The increase in DARPP-32 phosphorylation seen in wildtype (WT) mice after acute alcohol administration in the NAcSh was markedly reduced in MCH1-R knock-out (KO) mice. CONCLUSION: Our results suggest that MCH1-Rs regulate the rewarding properties of alcohol through interactions with signaling cascades downstream of DA receptors in the NAcSh.
Authors: Karl Björk; Anton Terasmaa; Hui Sun; Annika Thorsell; Wolfgang H Sommer; Markus Heilig Journal: Addict Biol Date: 2010-04-29 Impact factor: 4.280
Authors: Andrea Cippitelli; Camilla Karlsson; Janice L Shaw; Annika Thorsell; Donald R Gehlert; Markus Heilig Journal: Psychopharmacology (Berl) Date: 2010-07-14 Impact factor: 4.530
Authors: Donald R Gehlert; Kurt Rasmussen; Janice Shaw; Xia Li; Paul Ardayfio; Libbey Craft; Tamer Coskun; Hong Y Zhang; Yanyun Chen; Jeffrey M Witkin Journal: J Pharmacol Exp Ther Date: 2009-01-30 Impact factor: 4.030
Authors: Shinjae Chung; F Woodward Hopf; Hiroshi Nagasaki; Chun-Ying Li; James D Belluzzi; Antonello Bonci; Olivier Civelli Journal: Proc Natl Acad Sci U S A Date: 2009-04-02 Impact factor: 11.205
Authors: Elizabeth A Duncan; Joyce E Sorrell; Antoine Adamantidis; Therese Rider; Ronald J Jandacek; Randy J Seeley; Bernard Lakaye; Stephen C Woods Journal: Alcohol Clin Exp Res Date: 2007-06-05 Impact factor: 3.455
Authors: Guo-Qing Chang; Adam D Collier; Olga Karatayev; Gazal Gulati; Devi Sai Sri Kavya Boorgu; Sarah F Leibowitz Journal: Alcohol Clin Exp Res Date: 2020-02-26 Impact factor: 3.455
Authors: Staci E Engle; Patrick J Antonellis; Logan S Whitehouse; Ruchi Bansal; Michelle R Emond; James D Jontes; Robert A Kesterson; Kirk Mykytyn; Nicolas F Berbari Journal: Genesis Date: 2018-08 Impact factor: 2.487
Authors: Guo-Qing Chang; Olga Karatayev; Devi Sai Sri Kavya Boorgu; Sarah F Leibowitz Journal: J Neuroinflammation Date: 2020-07-10 Impact factor: 8.322